CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells
The assumption that mesenchymal stromal cell (MSC)-based-therapies are capable of augmenting physiological regeneration processes has fostered intensive basic and clinical research activities. However, to achieve sustained therapeutic success in vivo, not only the biological, but also the mechanical...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AO Research Institute Davos
2011-07-01
|
Series: | European Cells & Materials |
Subjects: | |
Online Access: | http://www.ecmjournal.org/journal/papers/vol022/pdf/v022a03.pdf |